The Oncosearch | Oncotarget

DNMT1 ablation suppresses tumorigenesis by inhibiting the self-renewal of esophageal cancer stem cells Research Paper

Ying Teng, Xiying Yu, Hui Yuan, Liping Guo, Wei Jiang, Shih-Hsin Lu

Published Apr 10, 2018 · Vol. 9, No. 27 · pp. 18896-18907

Differentiation-inducing therapeutic effect of Notch inhibition in reversing malignant transformation of liver normal stem cells via MET Research Paper

Hao Luo, Wei-Hui Liu, Hong-Yin Liang, Hong-Tao Yan, Ning Lin, Dong-Yu Li, Tao Wang, Li-Jun Tang

Published Apr 10, 2018 · Vol. 9, No. 27 · pp. 18885-18895

Findings of multiple HPV genotypes in cervical carcinoma are associated with poor cancer-specific survival in a Swedish cohort of cervical cancer primarily treated with radiotherapy Research Paper

Malin Kaliff, Bengt Sorbe, Louise Bohr Mordhorst, Gisela Helenius, Mats G. Karlsson, Gabriella Lillsunde-Larsson

Published Apr 10, 2018 · Vol. 9, No. 27 · pp. 18786-18796

Anabolic androgenic steroids and carcinogenicity focusing on Leydig cell: a literature review Review

Monica Salerno, Orazio Cascio, Giuseppe Bertozzi, Francesco Sessa, Antonietta Messina, Vincenzo Monda, Luigi Cipolloni, Antonio Biondi, Aurora Daniele, Cristoforo Pomara

Published Apr 10, 2018 · Vol. 9, No. 27 · pp. 19415-19426

Extracellular nicotinamide phosphoribosyltransferase (eNAMPT) is a novel marker for patients with BRAF-mutated metastatic melanoma Research Paper

Valentina Audrito, Antonella ManagÃ², Federica Zamporlini, Eliana Rulli, Federica Gaudino, Gabriele Madonna, Stefania D'Atri, Gian Carlo Antonini Cappellini, Paolo Antonio Ascierto, Daniela Massi, Nadia Raffaelli, Mario MandalÃ, Silvia Deaglio

Published Apr 10, 2018 · Vol. 9, No. 27 · pp. 18997-19005

PD-L1 expression in medulloblastoma: an evaluation by subgroup Research Paper

Allison M. Martin, Christopher J. Nirschl, Magda J. Polanczyk, W. Robert Bell, Thomas R. Nirschl, Sarah Harris-Bookman, Jillian Phallen, Jessica Hicks, Daniel Martinez, Aleksandra Ogurtsova, Haiying Xu, Lisa M. Sullivan, Alan K. Meeker, Eric H. Raabe, Kenneth J. Cohen, Charles G. Eberhart, Peter C. Burger, Mariarita Santi, Janis M. Taube, Drew M. Pardoll, Charles G. Drake, Michael Lim

Published Apr 10, 2018 · Vol. 9, No. 27 · pp. 19177-19191

Recombinant methioninase combined with doxorubicin (DOX) regresses a DOX-resistant synovial sarcoma in a patient-derived orthotopic xenograft (PDOX) mouse model Research Paper

Kentaro Igarashi, Kei Kawaguchi, Shukuan Li, Qinghong Han, Yuying Tan, Emily Gainor, Tasuku Kiyuna, Kentaro Miyake, Masuyo Miyake, Takashi Higuchi, Hiromichi Oshiro, Arun S. Singh, Mark A. Eckardt, Scott D. Nelson, Tara A. Russell, Sarah M. Dry, Yunfeng Li, Norio Yamamoto, Katsuhiro Hayashi, Hiroaki Kimura, Shinji Miwa, Hiroyuki Tsuchiya, Fritz C. Eilber, Robert M. Hoffman

Published Apr 10, 2018 · Vol. 9, No. 27 · pp. 19263-19272

Hyperandrogenism and insulin resistance contribute to hepatic steatosis and inflammation in female rat liver Research Paper

Yuehui Zhang, Fanci Meng, Xiaoyan Sun, Xue Sun, Min Hu, Peng Cui, Edvin Vestin, Xin Li, Wei Li, Xiao-Ke Wu, John-Olov Jansson, Linus R. Shao, HÃ¥kan Billig

Published Apr 6, 2018 · Vol. 9, No. 26 · pp. 18180-18197

Inhibition of IRES-dependent translation of caspase-2 by HuR confers chemotherapeutic drug resistance in colon carcinoma cells Research Paper

Amel Badawi, Abhiruchi Biyanee, Usman Nasrullah, Sofia Winslow, Tobias Schmid, Josef Pfeilschifter, Wolfgang Eberhardt

Published Apr 6, 2018 · Vol. 9, No. 26 · pp. 18367-18385

Validation and comparison of two NGS assays for the detection of EGFR T790M resistance mutation in liquid biopsies of NSCLC patients Research Paper

Claudia Vollbrecht, Annika Lehmann, Dido Lenze, Michael Hummel

Published Apr 6, 2018 · Vol. 9, No. 26 · pp. 18529-18539

Gefitinib or lapatinib with foretinib synergistically induce a cytotoxic effect in melanoma cell lines Research Paper

Ewelina Dratkiewicz, Katarzyna Pietraszek-Gremplewicz, Aleksandra Simiczyjew, Antonina Joanna Mazur, Dorota Nowak

Published Apr 6, 2018 · Vol. 9, No. 26 · pp. 18254-18268

A TRPV2 interactome-based signature for prognosis in glioblastoma patients Research Paper

Pau DoÃ±ate-MaciÃ¡n, Antonio GÃ³mez, Irene R. DÃ©gano, Alex PerÃ¡lvarez-MarÃn

Published Apr 6, 2018 · Vol. 9, No. 26 · pp. 18400-18409

Whole exome sequencing identifies mTOR and KEAP1 as potential targets for radiosensitization of HNSCC cells refractory to EGFR and β1 integrin inhibition Research Paper

Erik Klapproth, Ellen Dickreuter, Falk Zakrzewski, Michael Seifert, Andreas Petzold, Andreas Dahl, Evelin SchrÃ¶ck, Barbara Klink, Nils Cordes

Published Apr 6, 2018 · Vol. 9, No. 26 · pp. 18099-18114

Aloe-emodin as drug candidate for cancer therapy Research Paper

Nadire Ã–zenver, Mohamed Saeed, LÃ¼tfiye Ã–mÃ¼r Demirezer, Thomas Efferth

Published Apr 3, 2018 · Vol. 9, No. 25 · pp. 17770-17796

Selective inhibition of BCL-2 is a promising target in patients with high-risk myelodysplastic syndromes and adverse mutational profile Research Paper

Veronika Reidel, Johanna Kauschinger, Richard T. Hauch, Catharina MÃ¼ller-Thomas, Niroshan Nadarajah, Rainer Burgkart, Burkhard Schmidt, Dirk Hempel, Anne Jacob, Julia Slotta-Huspenina, Ulrike HÃ¶ckendorf, Christian Peschel, Wolfgang Kern, Torsten Haferlach, Katharina S. GÃ¶tze, Stefanie Jilg, Philipp J. Jost

Published Apr 3, 2018 · Vol. 9, No. 25 · pp. 17270-17281

Capecitabine reverses tumor escape from anti-VEGF through the eliminating CD11b^high/Gr1^high myeloid cells Research Paper

Toshiki Iwai, Yui Harada, Hiroshi Saeki, Eiji Oki, Yoshihiko Maehara, Yoshikazu Yonemitsu

Published Apr 3, 2018 · Vol. 9, No. 25 · pp. 17620-17630

BNIP3 modulates the interface between B16-F10 melanoma cells and immune cells Research Paper

Erminia Romano, Nicole Rufo, Hannelie Korf, Chantal Mathieu, Abhishek D. Garg, Patrizia Agostinis

Published Apr 3, 2018 · Vol. 9, No. 25 · pp. 17631-17644

Novel drug-resistance mechanisms of pemetrexed-treated non-small cell lung cancer Research Paper

Ryosuke Tanino, Yukari Tsubata, Nanae Harashima, Mamoru Harada, Takeshi Isobe

Published Mar 30, 2018 · Vol. 9, No. 24 · pp. 16807-16821

Antiapoptotic BCL-2 proteins determine sorafenib/regorafenib resistance and BH3-mimetic efficacy in hepatocellular carcinoma Research Paper

Anna Tutusaus, Milica Stefanovic, Loreto Boix, Blanca Cucarull, Aynara Zamora, Laura Blasco, Pablo GarcÃa de Frutos, Maria Reig, Jose C. Fernandez-Checa, Montserrat MarÃ, Anna Colell, Jordi Bruix, Albert Morales

Published Mar 30, 2018 · Vol. 9, No. 24 · pp. 16701-16717

Cisplatin liposome and 6-amino nicotinamide combination to overcome drug resistance in ovarian cancer cells Research Paper

Daniela Catanzaro, Silvia Nicolosi, Veronica Cocetta, Marika Salvalaio, Andrea Pagetta, Eugenio Ragazzi, Monica Montopoli, Gianfranco Pasut

Published Mar 30, 2018 · Vol. 9, No. 24 · pp. 16847-16860

Publication Alerts

European Cancer and Oncology Congress

Post-Publication Promotion

Search Oncotarget

DNMT1 ablation suppresses tumorigenesis by inhibiting the self-renewal of esophageal cancer stem cells Research Paper

Differentiation-inducing therapeutic effect of Notch inhibition in reversing malignant transformation of liver normal stem cells via MET Research Paper

Findings of multiple HPV genotypes in cervical carcinoma are associated with poor cancer-specific survival in a Swedish cohort of cervical cancer primarily treated with radiotherapy Research Paper

Anabolic androgenic steroids and carcinogenicity focusing on Leydig cell: a literature review Review

Extracellular nicotinamide phosphoribosyltransferase (eNAMPT) is a novel marker for patients with BRAF-mutated metastatic melanoma Research Paper

PD-L1 expression in medulloblastoma: an evaluation by subgroup Research Paper

Recombinant methioninase combined with doxorubicin (DOX) regresses a DOX-resistant synovial sarcoma in a patient-derived orthotopic xenograft (PDOX) mouse model Research Paper

Hyperandrogenism and insulin resistance contribute to hepatic steatosis and inflammation in female rat liver Research Paper

Inhibition of IRES-dependent translation of caspase-2 by HuR confers chemotherapeutic drug resistance in colon carcinoma cells Research Paper

Validation and comparison of two NGS assays for the detection of EGFR T790M resistance mutation in liquid biopsies of NSCLC patients Research Paper

Gefitinib or lapatinib with foretinib synergistically induce a cytotoxic effect in melanoma cell lines Research Paper

A TRPV2 interactome-based signature for prognosis in glioblastoma patients Research Paper

Whole exome sequencing identifies mTOR and KEAP1 as potential targets for radiosensitization of HNSCC cells refractory to EGFR and β1 integrin inhibition Research Paper

Aloe-emodin as drug candidate for cancer therapy Research Paper

Selective inhibition of BCL-2 is a promising target in patients with high-risk myelodysplastic syndromes and adverse mutational profile Research Paper

Capecitabine reverses tumor escape from anti-VEGF through the eliminating CD11b^high/Gr1^high myeloid cells Research Paper

BNIP3 modulates the interface between B16-F10 melanoma cells and immune cells Research Paper

Novel drug-resistance mechanisms of pemetrexed-treated non-small cell lung cancer Research Paper

Antiapoptotic BCL-2 proteins determine sorafenib/regorafenib resistance and BH3-mimetic efficacy in hepatocellular carcinoma Research Paper

Cisplatin liposome and 6-amino nicotinamide combination to overcome drug resistance in ovarian cancer cells Research Paper

Publication Alerts

European Cancer and Oncology Congress

Oncoscience

Post-Publication Promotion

Search Oncotarget

DNMT1 ablation suppresses tumorigenesis by inhibiting the self-renewal of esophageal cancer stem cells Research Paper

Differentiation-inducing therapeutic effect of Notch inhibition in reversing malignant transformation of liver normal stem cells via MET Research Paper

Findings of multiple HPV genotypes in cervical carcinoma are associated with poor cancer-specific survival in a Swedish cohort of cervical cancer primarily treated with radiotherapy Research Paper

Anabolic androgenic steroids and carcinogenicity focusing on Leydig cell: a literature review Review

Extracellular nicotinamide phosphoribosyltransferase (eNAMPT) is a novel marker for patients with BRAF-mutated metastatic melanoma Research Paper

PD-L1 expression in medulloblastoma: an evaluation by subgroup Research Paper

Recombinant methioninase combined with doxorubicin (DOX) regresses a DOX-resistant synovial sarcoma in a patient-derived orthotopic xenograft (PDOX) mouse model Research Paper

Hyperandrogenism and insulin resistance contribute to hepatic steatosis and inflammation in female rat liver Research Paper

Inhibition of IRES-dependent translation of caspase-2 by HuR confers chemotherapeutic drug resistance in colon carcinoma cells Research Paper

Validation and comparison of two NGS assays for the detection of EGFR T790M resistance mutation in liquid biopsies of NSCLC patients Research Paper

Gefitinib or lapatinib with foretinib synergistically induce a cytotoxic effect in melanoma cell lines Research Paper

A TRPV2 interactome-based signature for prognosis in glioblastoma patients Research Paper

Whole exome sequencing identifies mTOR and KEAP1 as potential targets for radiosensitization of HNSCC cells refractory to EGFR and β1 integrin inhibition Research Paper

Aloe-emodin as drug candidate for cancer therapy Research Paper

Selective inhibition of BCL-2 is a promising target in patients with high-risk myelodysplastic syndromes and adverse mutational profile Research Paper

Capecitabine reverses tumor escape from anti-VEGF through the eliminating CD11bhigh/Gr1high myeloid cells Research Paper

BNIP3 modulates the interface between B16-F10 melanoma cells and immune cells Research Paper

Novel drug-resistance mechanisms of pemetrexed-treated non-small cell lung cancer Research Paper

Antiapoptotic BCL-2 proteins determine sorafenib/regorafenib resistance and BH3-mimetic efficacy in hepatocellular carcinoma Research Paper

Cisplatin liposome and 6-amino nicotinamide combination to overcome drug resistance in ovarian cancer cells Research Paper

Capecitabine reverses tumor escape from anti-VEGF through the eliminating CD11b^high/Gr1^high myeloid cells Research Paper